Can Monitoring of Intrathoracic Impedance Reduce Morbidity and Mortality in Patients with Chronic Heart Failure? Rationale and Design of the Diagnostic Outcome Trial in Heart Failure (DOT-HF)
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Background: Chronic heart failure is associated with frequent hospitalisations which are often due to volume-overload decompensation. Monitoring of intrathoracic impedance, measured from an implanted device, can detect increases in pulmonary fluid retention early and facilitate timely treatment interventions. Objective: The DOT-HF trial is designed to investigate if ambulatory monitoring of intrathoracic impedance together with other device-based diagnostic information can reduce morbidity and mortality in patients with chronic heart failure who are treated with cardiac resynchronization therapy (CRT) and/or an implantable defibrillator (ICD). Methods: Approximately 2400 patients will be randomised in a 1:1 fashion to a management strategy with access to the diagnostic information from the implantable device (“access arm”), or a “control arm”, where this information is not made available. Study subjects fulfil standard indications for CRT and/or ICD as outlined in current guidelines. In the access arm, a fluid alert algorithm is used to give early warning of decreasing intrathoracic impedance indicating a high risk of an impending volume-overload decompensation. The primary endpoint of DOT-HF is the composite of all-cause mortality or heart failure hospitalisation. Secondary and exploratory endpoints include all-cause mortality, the impact on total health care utilization, quality of life and cost effectiveness. The study is expected to close recruitment during 2010 and to report in 2012.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure
Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., Domanski, M., Troutman, C., Anderson, J., Johnson, G., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043399 · Cited by 6,552
Bristow, M. R., Saxon, L. A., Boehmer, J., Krueger, S., Kass, D. A., De Marco, T., Carson, P., DiCarlo, L., DeMets, D., White, B. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032423 · Cited by 5,812 · cited 2×
“However, despite the improvements brought by devices, these patients are still at considerable risk for heart failure hospitalisation or death, as indicated by the annual event rates in the treatment arms reported in large scale heart failure device trials [19–21].”
BackgroundCardiac Resynchronization in Chronic Heart Failure
Abraham, W. T., Fisher, W. G., Smith, A. L., Delurgio, D. B., Leon, A. R., Loh, E., Kocovic, D. Z., Packer, M., Clavell, A. L., Hayes, D. L., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013168 · Cited by 4,648 · cited 1×
“Moreover, CRT has been demonstrated to improve cardiac function, exercise capacity and quality of life in patients with drug-refractory heart failure and prolonged QRS duration [23,24].”
BackgroundWRITING COMMITTEE MEMBERS, Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.167586 · Cited by 2,251
Cleland, J. G. F., Louis, A. A., Rigby, A. S., Janssens, U., & Balk, A. H. M. M. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.050 · Cited by 700 · cited 1×
“Furthermore, an increased level of patient surveillance by itself does not necessarily decrease the burden of heart failure related hospitalisation as recently shown in studies assessing the value of intensive nurse support [38] or home telemonitoring [39].”
BackgroundSolomon, S. D., Dobson, J., Pocock, S., Skali, H., McMurray, J. J. V., Granger, C. B., Yusuf, S., Swedberg, K., Young, J. B., Michelson, E. L., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.696906 · Cited by 681
Remote Monitoring of Implantable Cardioverter Defibrillators: A Prospective Analysis
SCHOENFELD, M. H., COMPTON, S. J., MEAD, R. H., WEISS, D. N., SHERFESEE, L., ENGLUND, J., & MONGEON, L. R. (2004) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2004.00524.x · Cited by 194
Cited by
Gheorghiade, M., Follath, F., Ponikowski, P., Barsuk, J. H., Blair, J. E. A., Cleland, J. G., Dickstein, K., Drazner, M. H., Fonarow, G. C., Jaarsma, T., et al. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq045 · Cited by 739
Self-citationvan Veldhuisen, D. J., Braunschweig, F., Conraads, V., Ford, I., Cowie, M. R., Jondeau, G., Kautzner, J., Muñoz Aguilera, R., Lunati, M., Yu, C. M., et al. (2011) · Circulation · doi:10.1161/circulationaha.111.043042 · Cited by 444
Self-citationConraads, V. M., Tavazzi, L., Santini, M., Oliva, F., Gerritse, B., Yu, C.-M., & Cowie, M. R. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr050 · Cited by 298
Self-citationDendale, P., De Keulenaer, G., Troisfontaines, P., Weytjens, C., Mullens, W., Elegeert, I., Ector, B., Houbrechts, M., Willekens, K., & Hansen, D. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfr144 · Cited by 242
Pandor, A., Thokala, P., Gomersall, T., Baalbaki, H., Stevens, J., Wang, J., Wong, R., Brennan, A., & Fitzgerald, P. (2013) · Health Technol Assess · doi:10.3310/hta17320 · Cited by 159
Metadata
- Authors
- Braunschweig, F., Ford, I., Conraads, V., Cowie, M. R., Jondeau, G., Kautzner, J., Lunati, M., Aguilera, R. M., Yu, C. M., Marijianowski, M., Borggrefe, M., van Veldhuisen, D. J., & DOT-HF steering committee and investigators
- Venue
- European Journal of Heart Failure
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-09-01
- Volume
- 10
- Issue
- 9
- Pages
- 907-916
- ISSN
- 1388-9842 (ISSN-L)
- 1879-0844
- OpenAlex
- W1997785532
- Cited by
- 60
- References
- 7
- FWCI
- 7.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.